ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
62.98
-1.25 (-1.95%)
Jul 17, 2024, 4:00 PM EDT - Market closed

ANI Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 1998
Cash & Equivalents
228.6221.1253.23100.312.8767.36
Upgrade
Short-Term Investments
9.6600000
Upgrade
Cash & Cash Equivalents
238.25221.1253.23100.312.8767.36
Upgrade
Cash Growth
251.63%315.38%-46.93%679.51%-80.90%40.25%
Upgrade
Receivables
172.42162.08165.44128.5395.7972.13
Upgrade
Inventory
113.84111.2105.3681.6960.848.16
Upgrade
Other Current Assets
16.0525.4220.2311.260.860.04
Upgrade
Total Current Assets
540.56519.82344.26321.78170.32187.7
Upgrade
Property, Plant & Equipment
48.5344.5943.2552.6741.2740.55
Upgrade
Long-Term Investments
000500
Upgrade
Goodwill and Intangibles
224.27237.23279.86322.01192.09183.97
Upgrade
Other Long-Term Assets
101.18102.7892.7270.1457.5144.58
Upgrade
Total Long-Term Assets
373.97384.61415.83449.82290.87269.09
Upgrade
Total Assets
914.52904.42760.09771.6461.19456.79
Upgrade
Accounts Payable
49.4336.6829.3122.9711.2614.61
Upgrade
Deferred Revenue
00000.080.45
Upgrade
Current Debt
0.850.850.850.8513.249.94
Upgrade
Other Current Liabilities
86.61107.9469.2863.7253.9836.68
Upgrade
Total Current Liabilities
136.89145.4899.4487.5478.5761.68
Upgrade
Long-Term Debt
284.61284.82285.67286.52172.44175.81
Upgrade
Other Long-Term Liabilities
16.2216.5336.4438.814.486.51
Upgrade
Total Long-Term Liabilities
300.82301.35322.11325.32186.93182.32
Upgrade
Total Liabilities
437.71446.82421.55412.86265.49244
Upgrade
Total Debt
285.46285.67286.52287.37185.69185.75
Upgrade
Debt Growth
-0.30%-0.30%-0.30%54.76%-0.03%1.49%
Upgrade
Retained Earnings
-62.33-80.13-97.29-47.77-4.9717.58
Upgrade
Comprehensive Income
9.418.8612.17-3.06-11.44-4.87
Upgrade
Shareholders' Equity
451.96432.75313.69333.89195.7212.79
Upgrade
Net Cash / Debt
-47.21-64.55-233.29-187.07-172.82-118.39
Upgrade
Net Cash Per Share
-2.43-3.55-14.35-14.85-14.44-9.83
Upgrade
Working Capital
403.67374.34244.82234.2491.76126.02
Upgrade
Book Value Per Share
23.2723.7919.2926.5116.3617.67
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).